[1]Word Health Organization.Global tuberculosis report 2015.Geneva:Word Health Organization,2015:67. [2]徐永先.内消瘰疬丸治疗初治肺结核37例疗效观察[J].中西医结合心血管病杂志,2016,4(3):72-74. [3]杨芬.内消瘰疬丸联合抗结核药物治疗颈淋巴结结核40例疗效观察[J].中医药导报,2012,18(8):103-104. [4]FALZON D,JARAMILLO E,SCHNEMANN H J,et al.Who guideline for the programmatic management of drugresistant tuberculosis:2011 update[J].The European Respiratory Journal,2011,38(3):516-528. [5]尤旭华,李桂琴.肺结核治疗现状及展望[J].临床进展,2012,14(20):10. [6]陈福连.扶正抗痨膏配合西药治疗浸润型肺结核疗效观察[J].现代中西医结合杂志,2009,18(10):1131-1132. [7]ELBEHAIRY A F,CLAVAGLIA C E,WEBB K A,et al.Pulmonary Gas Exchange Abnormalities in Mild Chronic Obstructive Pulmonary Disease.Implications for Dyspnea and Exercise Intolerance[J].Am J Respir Crit Care Med,2015,191(12):1384-1394. [8]Nunn AJ, Rusen ID, Deun AV, et al. Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial [J]. Trials, 2014, 15(1):1 -10. [9] 陈文明,陈欣,王忠刚,等.1056例肺结核患者耐药性分析[J].临床肺科杂志,2012,17(2):296 -297. [10]陈妍.莫西沙星联合抗结核药治疗耐药性结核临床疗效观察[J].临床肺科杂志,2013,18(2):309-311. [11]覃舒扬.莫西沙星与左氧氟沙星联合HRZE化疗方案用于多耐药性肺结核中的临床对比研究[J].临床和实验医学杂志,2014,(12):1003-1006.
|